| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ALK-Rearranged Non–Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism
|
Zer, Alona
|
|
2017
|
18 |
2 |
p. 156-161
6 p.
|
artikel
|
| 2 |
Assessing PDL-1 and PD-1 in Non–Small Cell Lung Cancer: A Novel Immunoscore Approach
|
Paulsen, Erna-Elise
|
|
2017
|
18 |
2 |
p. 220-233.e8
2.3299999781E10 p.
|
artikel
|
| 3 |
Association of PD-1, PD-L1, and CTLA-4 Gene Expression and Clinicopathologic Characteristics in Patients With Non–Small-Cell Lung Cancer
|
Lafuente-Sanchis, Aránzazu
|
|
2017
|
18 |
2 |
p. e109-e116
nvt p.
|
artikel
|
| 4 |
Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non–Small-Cell Lung Cancer – Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial
|
Swaminath, Anand
|
|
2017
|
18 |
2 |
p. 250-254
5 p.
|
artikel
|
| 5 |
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer
|
Okuma, Hitomi Sumiyoshi
|
|
2017
|
18 |
2 |
p. 234-240.e2
23767 p.
|
artikel
|
| 6 |
Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non–Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery
|
Santarpia, Mariacarmela
|
|
2017
|
18 |
2 |
p. 178-188.e4
1.879823E6 p.
|
artikel
|
| 7 |
Development of a Protein Biomarker Panel to Detect Non–Small-Cell Lung Cancer in Korea
|
Jung, Young Ju
|
|
2017
|
18 |
2 |
p. e99-e107
nvt p.
|
artikel
|
| 8 |
Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non–Small-Cell Lung Cancer
|
Sjøblom, Bjørg
|
|
2017
|
18 |
2 |
p. e129-e136
nvt p.
|
artikel
|
| 9 |
Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer
|
Morimoto, Masahiro
|
|
2017
|
18 |
2 |
p. e117-e127
nvt p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2017
|
18 |
2 |
p. A2-
1 p.
|
artikel
|
| 11 |
Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer
|
Menter, Alex R.
|
|
2017
|
18 |
2 |
p. 189-197.e3
196812 p.
|
artikel
|
| 12 |
Effect of Thoracic Radiotherapy Timing and Fractionation on Survival in Nonmetastatic Small Cell Lung Carcinoma
|
Wong, Andrew T.
|
|
2017
|
18 |
2 |
p. 207-212
6 p.
|
artikel
|
| 13 |
Hippocampal-Sparing Whole-Brain Radiotherapy for Lung Cancer
|
Zhao, Ren
|
|
2017
|
18 |
2 |
p. 127-131
5 p.
|
artikel
|
| 14 |
Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non–small-cell Lung Cancer
|
Reddy, Jay P.
|
|
2017
|
18 |
2 |
p. 141-148
8 p.
|
artikel
|
| 15 |
Location Matters: Stage I Non–Small-cell Carcinomas of the Lower Lobes Treated With Stereotactic Body Radiation Therapy Are Associated With Poor Outcomes
|
Shaverdian, Narek
|
|
2017
|
18 |
2 |
p. e137-e142
nvt p.
|
artikel
|
| 16 |
Matched-Pair Analysis of High Dose Versus Standard Dose Definitive Chemoradiation for Locally Advanced Non–Small-Cell Lung Cancer
|
Johnson, Matthew D.
|
|
2017
|
18 |
2 |
p. 149-155
7 p.
|
artikel
|
| 17 |
MET Gene Amplification and Overexpression in Chinese Non–Small-Cell Lung Cancer Patients Without EGFR Mutations
|
Song, Zhengbo
|
|
2017
|
18 |
2 |
p. 213-219.e2
21688 p.
|
artikel
|
| 18 |
Phase II Study of the EGFR-TKI Rechallenge With Afatinib in Patients With Advanced NSCLC Harboring Sensitive EGFR Mutation Without T790M: Okayama Lung Cancer Study Group Trial OLCSG 1403
|
Oda, Naohiro
|
|
2017
|
18 |
2 |
p. 241-244
4 p.
|
artikel
|
| 19 |
Predictors and Patterns of Regional Recurrence Following Lung SBRT: A Report From the Elekta Lung Research Group
|
Giuliani, Meredith E.
|
|
2017
|
18 |
2 |
p. 162-168
7 p.
|
artikel
|
| 20 |
Pretreatment Red Blood Cell Total Folate Concentration Is Associated With Response to Pemetrexed in Stage IV Nonsquamous Non–Small-cell Lung Cancer
|
Bagley, Stephen J.
|
|
2017
|
18 |
2 |
p. e143-e149
nvt p.
|
artikel
|
| 21 |
Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non–Small-Cell Lung Cancer After Curative Surgical Resection
|
Lee, Jeong Won
|
|
2017
|
18 |
2 |
p. 198-206
9 p.
|
artikel
|
| 22 |
Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non–Small-cell Lung Cancer: A Systematic Review
|
Falkson, Conrad B.
|
|
2017
|
18 |
2 |
p. 105-121.e5
1.2099896E7 p.
|
artikel
|
| 23 |
Recent Advances and Future Strategies for Immune-Checkpoint Inhibition in Small-Cell Lung Cancer
|
Chae, Young Kwang
|
|
2017
|
18 |
2 |
p. 132-140
9 p.
|
artikel
|
| 24 |
Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall
|
Gao, Sarah J.
|
|
2017
|
18 |
2 |
p. 169-177.e4
1.769832E6 p.
|
artikel
|
| 25 |
Second-Line Treatment Selection in Patients With Non–Small-Cell Lung Cancer of Adenocarcinoma Histology: Findings From a European Survey of Treating Physicians
|
Girard, Nicolas
|
|
2017
|
18 |
2 |
p. e89-e97
nvt p.
|
artikel
|
| 26 |
Table of Contents
|
|
|
2017
|
18 |
2 |
p. A8-A12
nvt p.
|
artikel
|
| 27 |
Three-Arm Randomized Trial of Sodium Alginate for Preventing Radiation-Induced Esophagitis in Locally Advanced Non–Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: The OLCSG1401 Study Protocol
|
Ninomiya, Kiichiro
|
|
2017
|
18 |
2 |
p. 245-249
5 p.
|
artikel
|
| 28 |
W‘ALK’ Into the Next Stage
|
Toyokawa, Gouji
|
|
2017
|
18 |
2 |
p. 122-126
5 p.
|
artikel
|
Tijdschrift beschrijving